tiprankstipranks
AbbVie presents results from ongoing Phase 3 study of oral atogepant
PremiumThe FlyAbbVie presents results from ongoing Phase 3 study of oral atogepant
13d ago
AbbVie pullback brings attractive entry point, says JPMorgan
PremiumThe Fly
AbbVie pullback brings attractive entry point, says JPMorgan
15d ago
AbbVie (NYSE:ABBV) Trims EPS Outlook, Stock Drops
PremiumMarket News
AbbVie (NYSE:ABBV) Trims EPS Outlook, Stock Drops
20d ago
Fly Insider: NextNav,  Akamai among week’s notable insider trades
PremiumThe FlyFly Insider: NextNav, Akamai among week’s notable insider trades
1M ago
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
1M ago
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PremiumPress Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
1M ago
AbbVie price target raised to $190 from $188 at Guggenheim
PremiumThe FlyAbbVie price target raised to $190 from $188 at Guggenheim
1M ago
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
1M ago
Allergan Aesthetics announces FDA approval of JUVEDERM VOLUMA XC
PremiumThe Fly
Allergan Aesthetics announces FDA approval of JUVEDERM VOLUMA XC
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100